GlassScriptPhysician profile
Melissa Counihan
NPI 1063655074
$1,859.64
in general payments reported to CMS, 2019-2025
24 companies · $487 in 2025
The $487 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $36.85 · 2021: $168 · 2022: $414 · 2023: $202 · 2024: $347 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.60 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $240.86 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $183.94 | 2022-2024 | |
| Channel Medsystems, INC. | $164.07 | 2022 | |
| Minerva Surgical, INC | $113.89 | 2025 | |
| Millicent US INC | $95.79 | 2024-2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $95.23 | 2024-2025 | Slynd, Twirla |
| Therapeuticsmd, INC. | $87.09 | 2019-2022 | |
| Pfizer INC. | $77.91 | 2019-2024 | |
| Coopersurgical, INC. | $66.86 | 2019-2025 | Endosee, Paragard T 380a |
| Evofem Biosciences, INC. | $53.36 | 2022 | |
| Organon LLC | $53.17 | 2024 | |
| Optumhealth Care Solutions, LLC | $46.64 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Biogen, INC. | $45.82 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $41.87 | 2021-2025 | Gardasil 9 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $40.68 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $39.05 | 2023-2024 | Myfembree |
| Allergan, INC. | $37.30 | 2019 | |
| Lsi Solutions INC | $23.93 | 2025 | Fornisee |
| Medtronic, INC. | $18.39 | 2025 | Interstim |
| Agile Therapeutics, INC. | $16.48 | 2023 | Twirla |
| Meditrina | $16.00 | 2024 | |
| Myovant Sciences INC. | $14.51 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Counihan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.